期刊文献+

自拟振元汤治疗化疗后血小板减少的临床疗效评价 被引量:3

Evaluation of Self-made ZhenYuanTang in Treating Thrombopenia after Chemotherapy
下载PDF
导出
摘要 目的:观察自拟振元汤(由六味地黄丸化裁而成)治疗恶性肿瘤化疗所致血小板减少的临床疗效。方法:选择化疗后血小板在20×109/L~75×109/L间的患者共40例,其中治疗组(20例)给予振元汤治疗;对照组(20例)给予白介素-11治疗,观察外周血小板升至≥100×109/L时停药。结果:治疗组显效及总有效率优于对照组,并且血小板增长速度快,差异有统计学意义(P<0.05)。结论:中医药治疗化疗后血小板减少的临床疗效优于白介素-11,并且无明显副作用。 Objective: To observe curative effects of self-made ZhenYuanTang(changed from LiuWei DiHuang Wan) in treating thrombopenia,side effects of chemotherapy of malignancies.Method: 40 patients with platelet in the range of 20 ×10 9 /L ~75 ×10 9 /L after chemotherapy were randomized into treatment group administered with ZhenYuanTang and control group given by interleukin-11 on average.The medication was ceased when peripheral platelet rise to ≥100×10 9 /L.Result: Effective rate and total effective rate of treatment group were superior to that of control group with significant difference(P〈0.05).The growth speed of platelet was faster than the treatment.Conclusion: Curative effects of TCM in treating thrombopenia after chemotherapy are superior to interleukin-11 without obvious side effect.
出处 《西部中医药》 2012年第2期75-77,共3页 Western Journal of Traditional Chinese Medicine
关键词 振元汤 六味地黄丸 化学治疗 血小板减少 白介素-11 ZhenYuanTang LiuWei DiHuangWan chemotherapy thrombopenia interleukin-11
  • 相关文献

参考文献4

二级参考文献13

  • 1KUTER D J, BEGLEY CG. Recombinant human thrombopoietin : Basic bioloth and evaluation of clinical studies [ J ]. Blood, 2002 , Nov15 : 100(10) :3457-3469. 被引量:1
  • 2VADHAN- RAJ S, COHEN V , BUESO- RAMOS. C Thrombopoietic growth factors and cytokines [ J ]. Curt hematol Rep,2005,4 ( 2 ) : 137- 144. 被引量:1
  • 3CHARLES I. Thrombopoietin in the treatment of acute myeloidleukemia and in stem- cell transplantation [ J ]. Semin Hematol,2000,37 ( Suppl 4)35-40. 被引量:1
  • 4Saitoh M,Taguchi K,Momose K,et al.Recombinant human interleukin-11 improved carboplation-induced thrombocytopenia without antitumor activities in mice bearing Lewis lung carcinoma cells[J].Cancer Chemother Pharmacol,2002,49(2):161-166. 被引量:1
  • 5Saitoh M,Taguchi K,Yasuda S,et al.Thrombopoietic activity of recombinant human interleukin-11 in nonhuman primates with ACNU-induced thrombocytopenia[J].J Interferon Cytokine Res,2000,20(6):539-555. 被引量:1
  • 6Tsimberidou AM,Giles FJ,khour I,et al.Low-dose interleukin-11 in patients with bone marrow failure:update of the M.D.Anderson cancer center experience[J].Ann Oncol,2005,16(1):139-145. 被引量:1
  • 7Soda H,Raymond E,Sharma S,et al.Recombinant human interleukin-11 is unlikely to stimulate the growth of the most common solid tumors[J].Anticancer Drugs,1999,10(1):97-101. 被引量:1
  • 8中华人民共和国卫生部.中药新药临床研究指导原则[S] 第1辑[Z].,1993.. 被引量:21
  • 9刘一,吕欣,董振香.重组人血小板生成素的药理作用和临床评价[J].中国新药杂志,2008,17(3):254-258. 被引量:19
  • 10赖伏英,方芳,孙黎,何群,陈朝晖,方云祥.重组人白介素11对豚鼠血小板减少的治疗作用[J].湖南医科大学学报,2002,27(1):19-20. 被引量:11

共引文献21

同被引文献76

引证文献3

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部